Insider Shareholders with Direct Ownership of Pyxis Oncology, Inc. (PYXS)
This section provides a comprehensive overview of the insiders with direct ownership of Pyxis Oncology, Inc. (PYXS). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Pyxis Oncology, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Pfizer Inc
> 10% Shareholder |
1,811,594 | 0 | 5,952,263 $10.1 Million | 1 |
Mar 17, 2023
Added 23.33%
|
| 2,742,338 | 0 | 2,742,338 $4.63 Million | 1 |
Oct 13, 2021
Added 50.0%
|
|
|
Lara Sullivan
Chief Executive Officer |
2,326,393 | 221,300 | 2,403,882 $4.06 Million | 10 |
Sep 18, 2023
Reduced 0.35%
|
|
Connealy Pamela Yanchik
CFO & COO |
1,142,242 | 36,949 | 1,110,293 $1.88 Million | 11 |
Mar 26, 2024
Added 22.84%
|
|
Jay Feingold
Chief Medical Officer |
730,345 | 0 | 730,345 $1.23 Million | 5 |
Mar 24, 2023
Added 22.32%
|
| 243,793 | 0 | 413,015 $697,995 | 4 |
Mar 26, 2024
Added 7.86%
|
|
|
Jitendra Wadhane
SVP, Chief Accounting Officer |
349,773 | 0 | 398,421 $673,331 | 7 |
Mar 26, 2024
Added 24.81%
|
| 251,405 | 0 | 251,405 $424,874 | 4 |
Mar 26, 2024
Added 12.29%
|
|
| 241,405 | 0 | 241,405 $407,974 | 3 |
Mar 26, 2024
Added 12.73%
|
|
| 206,186 | 0 | 206,186 $348,454 | 2 |
Mar 24, 2023
Added 40.33%
|
|
| 96,805 | 0 | 96,805 $163,600 | 2 |
Mar 26, 2024
Added 28.58%
|
|
| 66,831 | 0 | 66,831 $112,944 | 1 |
Mar 31, 2022
Added 50.0%
|
|
| 38,741 | 0 | 38,741 $65,472 | 1 |
Mar 26, 2024
Added 50.0%
|
|
| 6,000 | 0 | 6,000 $10,140 | 1 |
Jun 07, 2024
Added 50.0%
|